The bio-complex "reaction pattern in vertebrate cells" (RiV) is mainly represented by characteristic exosome-like particles --probably as reaction products of cells to specific stress. The transcription factor NF-kappaB plays a central role in inflammation. We tested the hypothesis that RiV particle preparations (RiV-PP) reduce cellular adhesion molecule ( 
INTRODUCTION
One of the initial events in atherogenesis is the activation of endothelial cells, which then express cell surface-adhesion molecules (CAM) such as the intercellular-adhesion molecule (ICAM-1), the vascular cell-adhesion molecule (VCAM-1), and the endothelial leukocyte adhesion molecule (E-selectin) (1) . ICAM-1 belongs to the immunoglobulin (IgG) superfamily and interacts with the leukocyte function-associated antigen-1. It is basally expressed on many different cell types: e.g., vascular endothelial cells, epithelial cells, and macrophages. ICAM-1 expression can be significantly increased in the presence of cytokines (TNF-α, IL-1, IFNγ) (2, 3) . VCAM-1 is a member of the IgG superfamily as well and supports the adhesion of several cell types, including lymphocytes and monocytes, to leukocytes. E-selectin belongs to the family of selectins and mediates the initial interactions of both leukocytes and platelets with endothelial cells (1) .
The promoters of the genes coding for these CAM contain consensus binding sites for the transcription factor, nuclear factor-κB (NF-κB) (4) . NF-κB plays a central role in normal physiologic and numerous pathologic conditions as it induces transcription of pro-inflammatory genes, adhesion molecules, and matrix metalloproteinases (4) (5) (6) . In its inactive form, NF-κB is localized in the cytoplasm as part of a complex with its inhibitor IκB. Upon stimulation with cytokines e.g. TNF-α, IκB becomes degraded, then NF-κB is released and translocated into the nucleus (5) .
The bio-complex RiV (reaction pattern in vertebrate cells) is probably a reaction product of the cells to specific stress and mainly represented by characteristic exosome-like RiV particles with a diameter of 50 ± 15 nm and smaller RiV-specific units (7, 8) . RiV particle preparations (RiV-PP) of bovine origin exerted protective effects against foot-and-mouth disease in guinea pigs (8) . The growth of spontaneous mammary carcinomas in mice and of mouse myeloma was significantly reduced (I. Klöting, personal communication, and (9)).
RiV particle preparations contain protein and nucleic acids components (Table 1) . No DNA molecules and no RNA of known viruses were found in any RiV particle preparations (10) .
At present, nothing is known about the effects of RiV-PP on endothelial cells. Therefore, we tested the hypothesis that RiV particle preparations reduce cytokine-induced expression of cellular adhesion molecules in human umbilical vein endothelial cells (HUVEC 
Nucleic acids
Ribosomal RNA Cellular mRNA sequences RNA with unknown sequence Table 1 . Selected identified components of RiV particle preparations (10) 
RESULTS

Effects of RVi-PP on TNF-α-induced expression of cellular adhesion molecules
Cell viability was analyzed by Trypan Blue exclusion. Treatment of confluent HUVEC with RiV-PP (dilution of 1:200) for four hours had no significant effects on cell viability (data not shown). Under normal conditions, mRNA expression of ICAM-1 (＜1%), VCAM-1 (＜2%), and E-selectin (＜1%) was very low after four hours compared to TNF-α-treated cells (100%; Fig. 1A-C) . Incubation with RiV-PP (1:200) for four hours did not affect the basal CAM expression in medium-treated cultures. Exposure of cells to TNF-α (10 ng/ml) for four hours induced strong up-regulation of CAM mRNA expression (Fig. 1A-C) . Pre-treatment with RiV-PP partially inhibited the upregulation of ICAM-1 (65.5 ± 10.3%, P ＜ 0.05 vs. TNF-α-treated cells), and VCAM-1 (71.1 ± 12.3%, P ＜ 0.05 vs. TNF-α-treated cells) mRNA expression by TNF-α, but had no relevant effects on E-selectin mRNA expression (103.3 ± 30.5%).
To investigate whether the effects of RiV-PP were detectable at the protein level as well we performed flow cytometry to quantify surface expression ( Fig. 1D-F) . Basal CAM surface expression in the absence (ICAM-1 2.9 ± 0.1%; VCAM-1 13.2 ± 3.0%; E-selectin 5.4 ± 0.6%) or presence of RiV-PP (ICAM-1 18.0 ± 4.3%, VCAM-1 13.7 ± 2.1%, E-selectin 7.5 ± 0.6%) was low, but markedly enhanced by treatment with TNF-α (100%). Cytokine-induced ICAM-1 surface expression was mar-http://bmbreports.org Table 2 . Effects of RiV-PP on endothelial CAM expression after 16 hours. Confluent HUEVC were treated with RiV-PP (dilution 1:200) for 30 minutes, then TNF-α (10 ng/ml) was added. Cells were harvested after 16 hours. Reverse transcription PCR was used for mRNA quantification; surface expression was analyzed by cell ELISA, and soluble forms were quantified with ELISA. Data are presented as a percentage of TNF-α-treated cells. *P ＜ 0.05 compared to TNF-α-treated cells
Fig. 2.
Effects of RiV-PP on p50 and p65 translocation and IκB degradation. TNF-α-stimulated (10 ng/ml) HUVEC were treated for one hour. Fluorescence microscopy was performed as described in the methods section. Cytoplasmic and nuclear protein extracts were prepared as described in the methods section. (A), (C) localization of p50 and p65 was analysed by fluorescence microscopy. Images show staining for p50 and p65 (green, upper panels) and nuclear staining with TOTO (red, middle panels) magnified 400-times. Overlay images are shown in the lower panels. (B), (D) translocation of p50 and p65 from the cytoplasm to the nucleus was assessed by ELISA. Two micrograms of nuclear protein were used in each experiment. (E) samples were separated on a 10% polyacrylamide gel, transferred to PVDF membrane and immunostained for IκBα and after stripping for GAPDH as loading control followed by ECL detection. Representative photographs are shown of one immunoblot from four independent experiments. (F) densitometric band intensities were normalized to GAPDH. Data (means ± SEM) are expressed as a percentage of TNF-α-treated cells from four independent cell preparations. Open bars: medium-treated cells; grey bars: RiVtreated cells in the absence of TNF-α; hatched bars: TNF-α-treated cells; greyhatched bars: RiV-PP/ TNF-treated cells. *P ＜ 0.05 versus TNF-α-treated cells.
ginally albeit significantly reduced in RiV-PP-treated HUVEC (92.0 ± 5.6%, P ＜ 0.05). However, pre-treatment of HUVEC with RiV-PP failed to reduce TNF-stimulated surface expression of VCAM-1 (105.1 ± 10.7%), and E-selectin (9.9 ± 1.0%).
After 16 hours, pre-treatment of HUVEC with RiV-PP significantly enhanced ICAM-1 mRNA expression to 206.2 ± 66.6% (n = 6) compared to cytokine-treated cells (100%, Table 2 ). No relevant effects of RiV-PP were observed for ICAM-1 surface expression; VCAM-1 surface expression was marginally increased to 109.2 ± 2.4% (n = 5, P ＜ 0.05 vs. TNF-treated cells). After pre-treatment with RiV-PP and stimulation with TNF-α, VCAM-1 (240.0 ± 129.3%, n = 5) and E-selectin (178.5 ± 52.3%; n = 6) mRNA expression were significantly increased compared to expression in TNF-α-treated cells (100%) too. TNF-α-induced E-selectin surface expression was not significantly altered by the treatment with RiV-PP.
As CAM can be shed from the cell surface, we determined whether RiV-PP-treatment affected shedding by measuring the amount of soluble (s) CAM in TNF-α-stimulated HUVEC ( 2). After 16 hours, TNF-α induced shedding of the soluble forms of CAM when compared to un-stimulated cells. Pretreatment of TNF-stimulated HUVEC with RiV-PP increased the levels of sICAM-1 and sE-selectin but not sVCAM-1 significantly in cell culture supernatants.
RiV-PP attenuates nuclear translocation of the NF-κB subunits p50 and p65
To test whether the reducing effects of RiV-PP on adhesion molecule mRNA expression after 4 hours was mediated by NF-κB signalling, we quantified the nuclear translocation of two members of the NF-κΒ family of transcription factors, p50 and p65. In the absence of TNF-α, p50 and p65 are localized in the cytoplasm (green signals, Fig. 2A, C) . Nuclei were stained with TOTO (red signals). RiV-PP alone maintained p50 and p65 translocation. After one hour, TNF-α (10 ng/ml) induced nuclear translocation of both proteins which was reduced if the cells have been pre-treated with RiV-PP ( Fig. 2A, C) . To quantify the nuclear amounts of p50 and p65, we performed p50-and p65-specific ELISAs (Fig. 2B, D) . Pre-incubation of HUVEC with RiV-PP for 60 minutes before stimulation with the cytokine significantly reduced p50 (85.7 ± 4.1%, n = 4) and p65 (85.0 ± 1.8%, n = 4) nuclear translocation. Addition of a NF-κB consensus oligonucleotide in a molar excess as a competitor for NF-κB binding prevented TNF-α-induced p50 and p65 nuclear translocation (data not shown). Additionally, we analysed IκBα and its degradation in cytoplasmic protein extracts (Fig. 3E) . After 60 minutes, basal IκBα expression was 170.4 ± 28.2% of TNF-α-treated cells (100%). Pre-treatment with RiV-PP resulted in attenuation of TNF-α-mediated IκBα degradation (133.8 ± 11.6%, n = 4, P ＜ 0.05 vs. TNF-α-treated cells).
Heat-treatment of RiV-PP affects surface expression of adhesion molecules
A previous study reported that RiV-PP particle preparations consist of both a heat-sensitive and a heat-stable reactive component (7). Therefore, we tested whether the RiV-PP-mediated effects on p50 and p65 localization and TNF-α-induced CAM surface expression were affected by heat-inactivation (hi) of RiV-PP for 10 minutes prior of application to HUVEC. TNF-induced nuclear localization of p50 and p65 was decreased by pre-treatment with heat-inactivated RiV-PP based on immunofluorescence analysis ( Fig. 2A, B) . There was no significant effect of hiRiV-PP on TNF-α-induced ICAM-1 surface expression http://bmbreports.org ( Fig. 3C-E) . However, hiRiV-PP led to a significant reduction in surface expression of VCAM-1 and E-selectin compared to the up-regulation of TNF-α-induced surface expression in HUEVC treated with native RiV-PP preparations.
DISCUSSION AND RESULTS
Cellular adhesion molecules are expressed on different cell types, e.g., vascular endothelial cells, epithelial cells, fibroblasts, and macrophages; their expression can be significantly increased in the presence of cytokines (TNF-α, IL-1, IFNγ), reactive oxygen species, and shear stress (1, 11) . The presented data show that treatment of HUVEC with native RiV preparations resulted in a reduction in TNF-a-stimulated CAM mRNA expression after four hours but resulted in a further increase of CAM surface expression after 16 hours. An anti-inflammatory effect after four hours is in accordance with the fact that annexin I, which exerts anti-inflammatory effects (12) , is a main component (up to approx. 20% of the protein contents) in RiV particle preparations (7) .
Adhesion molecule expression and expression of other proinflammatory endothelial gene products are essentially controlled by the transcription factor NF-κB (13) . In the present study, we demonstrated that RiV-PP diminishes IκBα degradation and reduces nuclear translocation of the NF-κB subunits p50 and p65 after one hour. Reduced nuclear translocation of NF-κB decreased both ICAM-1 and VCAM-1, but not E-selectin mRNA expression. This may be due to the involvement of other transcription factors besides NF-κB in E-selectin expression, e.g. activating transcription factor-2 (4) which may have not been affected by RiV-PP treatment. Furthermore, attenuation on the transcriptional level by RiV-PP is clearly in conflict with the observed increase in CAM surface expression after 16 hours. This may be due to the involvement of activator-protein-1 in CAM mRNA expression or by activation of the Jun N-terminal kinase/stress-activated protein kinase pathway (14) . Probably, this involvement or these pathways may not have been affected by the RiV-PP samples in our experimental setting. This may account for the increase in TNF-α-induced CAM mRNA expression despite the reduction in NF-κB activation.
In various states of different diseases, the membrane-bound forms of the adhesion molecules may be released as soluble forms. For example, ICAM-1 can be detected in significantly elevated levels in sera from patients with leukocyte adhesion deficiency compared to normal sera (15) . Cleavage in endothelial cells has been shown to be induced by TNF-α (16). The mechanisms of cleavage are evidently dependent on cell type and stimulus, since cleavage in HEK 293 cells was accelerated by phorbol ester, but not by TNF-α. In contrast, in tumour cell lines activation of matrix metalloproteinase-9 is necessary for proteolytical cleavage of the extra-cellular domain of ICAM-1 (17) .
Heat-inactivation of RiV-PP resulted in decreased CAM surface expression indicating that the responsible component(s) may be heat-sensitive. Previously, it was shown that RiV particles were surprisingly heat-stable and that boiling for up to 60 minutes did not affect the morphology and diameter of the particles in comparison to untreated samples. Furthermore, no difference was seen in the reaction of RiV-PP particles which had been boiled for 10 minutes to an anti-RiV-PP antiserum when compared to that of untreated samples by immunoelectron microscopy. On the other hand, using ELISA, the reactivity of such RiV-PP samples with a rabbit anti-RiV-PP antiserum was quickly reduced during the first minutes of boiling but reduction in reactivity was decelerated if samples were heat-treated for further 20 minutes (7). The non-linear inactivation may be due to the presence of more than one reactive component and these were inactivated at different time points. Additionally, the reduction in reactivity of RiV-PP differed from sample to sample which may have been due to the fact that various portions of further heat-sensitive components may be dependent on the purity of RiV-PP (7). Thus, RiV particle preparations seem to consist of heat-sensitive as well as heat-stable reactive components. Our data indicate that heattreatment, hence degradation of most proteins contained in RiV particle preparations, may inactivate the components necessary for the up-regulation of CAM mRNA expression after 16 hours. It may be possible that heat-treatment of RiV-PP prevents the translocation of members of the NF-κB protein family and that of further transcription factors such as AP-1 or Sp1 known to be involved in up-regulation of CAM expression in endothelial cells as well (18, 19) .
In a previous report, heat shock protein (HSP) 70 was shown to be a component of RiV-PP samples (10) . The importance of HSP70 for cancer therapy is already known. HSP70 supports the immune answer against tumours and stimulates the cytolytic activity of naive NK cells against HSP70-positive tumour target cells (20) . HSP70 may account for the effects of heat-stable RiV-PP particles. For example, in endothelial cells, a heat shock not only induces HSP70 expression and but also decreases TNF-α-induced ICAM-1 expression transcriptionally (21) . In contrast, heat shocking of respiratory epithelial cells resulted in NF-κB inhibition but TNF-induced ICAM-1 surface expression was not affected suggesting cell-type specific regulation of ICAM-1 expression under stress (21) .
We conclude that RiV-PP may contribute to an anti-inflammatory effect in HUVEC by reducing CAM mRNA expression via attenuation of p50 and p65 translocation. The reduction in mRNA expression is not reflected at the protein level due to enhanced surface expression after 16 hours in the presence of TNF-α. Further studies are necessary to clarify the diverse effects of RiV particle preparations on CAM expression in human endothelial cells.
MATERIALS AND METHODS
RiV samples
RiV samples (RiV-PP or bio-complex RiV preparations) from primary and diploid calf kidney cell cultures were prepared as http://bmbreports.org BMB reports described previously (7, 22) .
Cell culture
All chemicals were purchased from Sigma-Aldrich, Germany, unless otherwise stated. Human endothelial cells (HUVEC) were obtained from collagenase type II (Biochrom, Germany) digested umbilical cords and cultivated as described previously (23) . Cell viability was evaluated by Trypan Blue exclusion. HUVEC were pre-treated with RiV-PP (dilution of 1 : 200) for 30 minutes before stimulation with TNF-α (10 ng/ml) up to 16 hours.
Quantitative reverse transcription PCR
Quantification of CAM and GAPDH mRNA expression was performed using mRNA Assays-on-Demand TM (Applera Deutschland, Germany) with an Applied Biosystems ABI Prism 7700. Total RNA was isolated using standard procedures (Qiagen, Germany). Reverse transcription of 500 ng of RNA and PCR reactions for all samples were performed as described previously (24) . Relative gene expression data were analyzed using the 2 −ΔΔCt method.
Analysis of surface expression by flow cytometry (FACS)
Confluent cells were stimulated with TNF-α (10 ng/ml) for 4 or 16 hours to induce expression of the adhesion molecules. Surface expression of CAM was analyzed by ELISA as described previously (24) . For flow cytometry analysis, cells were incubated for 45 minutes with FITC-conjugated mouse monoclonal antibodies against human ICAM-1, VCAM-1, or E-selectin (R&D Systems, Germany) and washed three times with PBS/BSA at 4 o C. Cells were fixed in 1% paraformaldehyde/ PBS, harvested with trypsin-EDTA, and collected by centrifugation. After washing, at least 10.000 cells were analyzed using a FACSCalibur and CellQuest Software (BD Biosciences, Germany). Data were gated to exclude cell debris and were corrected for blank values obtained without the use of first antibodies. The soluble forms of CAM in cell culture supernatants were quantified by ELISA (Bender MedSystems, Austria).
Preparation of cytoplasmic proteins and Western blot analysis of IκB
Confluent cells were pre-treated with RiV-PP for 30 minutes, then TNF-α (10 ng/ml) was added for one hour. Cytoplasmic proteins were prepared and analyzed by SDS-PAGE as described earlier (24) . Detection of IκBα was performed with a monoclonal antibody against IκBα and a horseradish peroxidase-coupled antibody in an enhanced chemiluminescence (ECL) detection system (GE HealthCare, Germany). ECL images were scanned, and signals were quantified with TINA 2.09 g (raytest, Germany). Membranes were stripped and re-probed with an antibody against GAPDH (Sigma) to assess equal loading of the gels.
Preparation of nuclear proteins and quantification of NF-κB subunits p50 and p65
Preparation of nuclear proteins from 100,000 cells was performed with the Nuclear Extract Kit (Active Motif, Belgium) as described previously (24) . Protein concentrations were determined using a bicinchoninic acid assay (Pierce, Germany). Nuclear translocation of the NF-κB subunits p50 and p65 was assessed with the TransAM NF-κB Family Transcription Factor Kit (Active Motif, Belgium). Two micrograms of nuclear proteins were used per reaction. After addition of the secondary antibody, conjugated to horseradish peroxidase, colour was developed for 10 minutes at room temperature. Absorbance was read at 450 nm (reference wavelength 655) nm in a spectrophotometer (Victor2, PerkinElmer LAS, Germany).
Immunofluorescence microscopy
Adherent cells were permeabilized with 0.05% Triton X-100 in 2% paraformaldehyde for 5 minutes at room temperature. Cells were incubated with the primary antibodies against human p50 (BioLegend, San Diego, US) and p65 (Invitrogen) at 4 o C overnight. Primary antibodies were used at a dilution of 1:250. Cells were washed with 1x PBS and then incubated with goat anti-mouse Alexa Fluor Ⓡ 488-IgG (Invitrogen) for one hour. Nuclei were stained with TOTO (Sigma) for 15 seconds. Samples were mounted with Vectashield (Vector Laboratories, Burlingame, CA). Cells were analyzed using a Leica DM LB microscope (Leica Microsystems) equipped with appropriate filters.
Statistical analysis
Expression data are expressed as a percentage of TNF-α-treated cells (means ± SEM) for n preparations from different human umbilical cords. The effects of RiV-PP were analyzed using the Mann-Whitney U-test or nonparametric analysis of variance with Student-Newman-Keuls testing. A P value ＜ 0.05 was considered statistically significant.
